2,2'-anhydro-1-(4'-azido-3',5'-O-bis-(4-methoxy-tetrahydropyran-4-yl)-β-D-arabinofuranosyl)uracil | 1145869-32-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2,2'-anhydro-1-(4'-azido-3',5'-O-bis-(4-methoxy-tetrahydropyran-4-yl)-β-D-arabinofuranosyl)uracil
• 英文别名: (2R,4R,5S,6S)-4-azido-5-(4-methoxyoxan-4-yl)oxy-4-[(4-methoxyoxan-4-yl)oxymethyl]-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one
• CAS: 1145869-32-4
• 化学式: C₂₁H₂₉N₅O₉
• 分子量: 495.489
• InChiKey: HGCNIBFGFBGCKR-ZGPJWRFFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  121
• 氢给体数：
  0
• 氢受体数：
  11

反应信息

• 作为反应物：
  描述：

  2,2'-anhydro-1-(4'-azido-3',5'-O-bis-(4-methoxy-tetrahydropyran-4-yl)-β-D-arabinofuranosyl)uracil 在 水 、 potassium hydroxide 作用下， 以 乙醇 为溶剂， 反应 3.0h， 以92%的产率得到1-(4'-azido-3',5'-O-bis-(4-methoxy-tetrahydropyran-4-yl)-β-D-arabinofuranosyl)uracil
  参考文献：
  名称：

  The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine

  摘要：

  The discovery of 4'-azidocytidine (3) (R1479) (J. Biol. Chem. 2006, 281, 3793; Bioorg. Med. Chem. Lett. 2007, 17, 2570) as a potent inhibitor of RNA synthesis by NS5B (EC50 = 1.28 mu M), the RNA polymerase encoded by hepatitis C virus (HCV), has led to the synthesis and biological evaluation of several monofluoro and difluoro derivatives of 4'-azidocytidine. The most potent compounds in this series were 4'-azido-2'-deoxy-2',2'-difluorocytidine and 4'-azido-2'-deoxy-2'-fluoroarabinocytidine with antiviral EC50 of 66 nM and 24 nM in the HCV replicon system, respectively. The structure-activity relationships within this series were discussed. which led to the discovery of these novel nucleoside analogues with the most potent compound, showing more than a 50-fold increase in antiviral potency as compared to 4'-azidocytidine (3).

  DOI：

  10.1021/jm801595c
• 作为产物：
  描述：

  2,2'-anhydro-1-(4'-azido-β-D-arabinofuranosyl)uracil 、 4-methoxy-5,6-dihydro-2H-pyrane 在 camphor-10-sulfonic acid 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 48.0h， 以61%的产率得到2,2'-anhydro-1-(4'-azido-3',5'-O-bis-(4-methoxy-tetrahydropyran-4-yl)-β-D-arabinofuranosyl)uracil
  参考文献：
  名称：

  The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine

  摘要：

  The discovery of 4'-azidocytidine (3) (R1479) (J. Biol. Chem. 2006, 281, 3793; Bioorg. Med. Chem. Lett. 2007, 17, 2570) as a potent inhibitor of RNA synthesis by NS5B (EC50 = 1.28 mu M), the RNA polymerase encoded by hepatitis C virus (HCV), has led to the synthesis and biological evaluation of several monofluoro and difluoro derivatives of 4'-azidocytidine. The most potent compounds in this series were 4'-azido-2'-deoxy-2',2'-difluorocytidine and 4'-azido-2'-deoxy-2'-fluoroarabinocytidine with antiviral EC50 of 66 nM and 24 nM in the HCV replicon system, respectively. The structure-activity relationships within this series were discussed. which led to the discovery of these novel nucleoside analogues with the most potent compound, showing more than a 50-fold increase in antiviral potency as compared to 4'-azidocytidine (3).

  DOI：

  10.1021/jm801595c

文献信息

• The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine
  作者：David B. Smith、Genadiy Kalayanov、Christian Sund、Anna Winqvist、Tatiana Maltseva、Vincent J.-P. Leveque、Sonal Rajyaguru、Sophie Le Pogam、Isabel Najera、Kurt Benkestock、Xiao-Xiong Zhou、Ann C. Kaiser、Hans Maag、Nick Cammack、Joseph A. Martin、Steven Swallow、Nils Gunnar Johansson、Klaus Klumpp、Mark Smith

  DOI：10.1021/jm801595c

  日期：2009.5.14

  The discovery of 4'-azidocytidine (3) (R1479) (J. Biol. Chem. 2006, 281, 3793; Bioorg. Med. Chem. Lett. 2007, 17, 2570) as a potent inhibitor of RNA synthesis by NS5B (EC50 = 1.28 mu M), the RNA polymerase encoded by hepatitis C virus (HCV), has led to the synthesis and biological evaluation of several monofluoro and difluoro derivatives of 4'-azidocytidine. The most potent compounds in this series were 4'-azido-2'-deoxy-2',2'-difluorocytidine and 4'-azido-2'-deoxy-2'-fluoroarabinocytidine with antiviral EC50 of 66 nM and 24 nM in the HCV replicon system, respectively. The structure-activity relationships within this series were discussed. which led to the discovery of these novel nucleoside analogues with the most potent compound, showing more than a 50-fold increase in antiviral potency as compared to 4'-azidocytidine (3).